axitinib
First-Line Avelumab-Axitinib Combo Increases PFS for Patients With Advanced RCC
First-line treatment combining the immune checkpoint blocker avelumab (Bavencio, EMD Serono/Pfizer) with the ...
JANUARY 24, 2019
Investigators Identify Predictors of Long-Term Response to Axitinib in RCC
Patients with RCC are more likely to experience long-term response to axitinib (Inlyta, Pfizer) if they have early ...
APRIL 24, 2017
Dalantercept-Axitinib Combo Shows Promise for RCC
The combination of axitinib (Inlyta, Pfizer) and dalantercept, an activin receptor–like kinase 1 (ALK1) ...
JANUARY 16, 2017
Load more